Treating Cancer With Genetically Engineered T Cells

Trends in Biotechnology - Netherlands
doi 10.1016/j.tibtech.2011.04.009
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

182. Genetically Engineered Malignant Glioma-Specific T Cells Resistant to Glucocorticoids

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2010English

Immunotherapy of Metastatic Melanoma Using Genetically Engineered GD2-Specific T Cells

Clinical Cancer Research
Cancer ResearchOncology
2009English

Genetically-Engineered Mouse Pancreatic Cancer Models

Suizo
2010English

Genetically Engineered Mouse Models of Cancer

Science-Business eXchange
2008English

Genetically Engineered ER -Positive Breast Cancer Mouse Models

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2014English

Extrathymic Generation of Tumor-Specific T Cells From Genetically Engineered Human Hematopoietic Stem Cells via Notch Signaling

Cancer Research
Cancer ResearchOncology
2007English

Genetically Engineered T Cells Expressing a HER2-specific Chimeric Receptor Mediate Antigen-Specific Tumor Regression

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2008English

Antitumor Activity From Antigen-Specific CD8 T Cells Generated in Vivo From Genetically Engineered Human Hematopoietic Stem Cells

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2011English

Genetically Engineered Mucin Mouse Models for Inflammation and Cancer

Cancer and Metastasis Reviews
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy